Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2
Figure 1
Cardiac function detected by echocardiography. (a) EF, FS, LVEDd, and LVEDs in sham-operated group. (b) Increased EF and FS and decreased LVEDd and LVEDs in sham-operated rats. (c) Changes in EF in fosinopril sodium group. (d) Improvements in EF and FS in QSYQ group.
